Supragen
Executive Summary
Supragen wants to developing drugs and vaccines around a class of proteins called superantigens, which can trigger a massive immune response so strong it can induce toxic shock syndrome and may be part of the pathogenesis of other autoimmune, inflammatory and infectious diseases.